Aesthetic Dermatology Associates

Aesthetic Dermatology Associates, also operating as ADA Dermatology and Dermatology Associates, is a United States-based healthcare provider specializing in dermatological services. The organization delivers medical and aesthetic dermatology care to patients, managing sensitive health information including personal identifiers, diagnostic codes, and insurance details as part of its standard operations. Its service scope indicates a focus on outpatient clinical care within the dermatology sector, serving a patient population whose data is subject to healthcare privacy regulations. The confirmed impact of a single cybersecurity incident on over 33,000 individuals suggests a practice of a moderate to substantial size, with a significant patient footprint requiring robust data management systems. No explicit details regarding ownership structure, parent companies, or subsidiary relationships are provided in the available information.

The organization's operational context is notably defined by a documented cybersecurity breach that occurred on August 15, 2022. This incident involved unauthorized network access by the BianLian ransomware group, resulting in the theft and subsequent dark web publication of patient records. Aesthetic Dermatology Associates reported the breach to the Department of Health and Human Services, confirming the exposure of data for more than 33,000 people. However, the organization's public notifications to patients did not disclose that the stolen information had already been leaked online, a critical gap in its incident communication. The company acknowledged no evidence of data misuse following the leak and did not offer affected individuals complimentary identity theft mitigation or credit monitoring services at the time of reporting. This event highlights a specific vulnerability in the organization's cybersecurity defenses and its crisis response protocols, distinguishing its recent history within the healthcare provider landscape. The incident underscores the regulatory and reputational risks associated with ransomware attacks in the medical sector, particularly concerning the timeliness and completeness of patient notifications after a data compromise.